YU28800A - Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije - Google Patents
Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemijeInfo
- Publication number
- YU28800A YU28800A YU28800A YU28800A YU28800A YU 28800 A YU28800 A YU 28800A YU 28800 A YU28800 A YU 28800A YU 28800 A YU28800 A YU 28800A YU 28800 A YU28800 A YU 28800A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- hyperglycaemia
- medicament
- manufacture
- treatment
- insulin sensitisers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9721693.1A GB9721693D0 (en) | 1997-10-13 | 1997-10-13 | Novel treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU28800A true YU28800A (sh) | 2003-02-28 |
Family
ID=10820482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU28800A YU28800A (sh) | 1997-10-13 | 1998-10-12 | Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1023056A1 (xx) |
| JP (1) | JP2001519382A (xx) |
| KR (1) | KR20010024481A (xx) |
| CN (1) | CN1281359A (xx) |
| AP (1) | AP2000001787A0 (xx) |
| AU (1) | AU9547098A (xx) |
| BG (1) | BG104404A (xx) |
| BR (1) | BR9815219A (xx) |
| CA (1) | CA2306086A1 (xx) |
| CZ (1) | CZ20001297A3 (xx) |
| EA (1) | EA002659B1 (xx) |
| GB (1) | GB9721693D0 (xx) |
| HR (1) | HRP20000255A2 (xx) |
| HU (1) | HUP0003922A3 (xx) |
| ID (1) | ID24521A (xx) |
| IL (1) | IL135513A0 (xx) |
| NO (1) | NO20001898L (xx) |
| NZ (1) | NZ503862A (xx) |
| OA (1) | OA11683A (xx) |
| PL (1) | PL339813A1 (xx) |
| SK (1) | SK5312000A3 (xx) |
| TR (1) | TR200000958T2 (xx) |
| WO (1) | WO1999018943A1 (xx) |
| YU (1) | YU28800A (xx) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE186724T1 (de) * | 1987-09-04 | 1999-12-15 | Beecham Group Plc | Substituierte thiazolidindionderivate |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| US5457109A (en) * | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
-
1997
- 1997-10-13 GB GBGB9721693.1A patent/GB9721693D0/en not_active Ceased
-
1998
- 1998-10-12 AP APAP/P/2000/001787A patent/AP2000001787A0/en unknown
- 1998-10-12 HU HU0003922A patent/HUP0003922A3/hu unknown
- 1998-10-12 YU YU28800A patent/YU28800A/sh unknown
- 1998-10-12 CZ CZ20001297A patent/CZ20001297A3/cs unknown
- 1998-10-12 PL PL98339813A patent/PL339813A1/xx unknown
- 1998-10-12 BR BR9815219-0A patent/BR9815219A/pt not_active Application Discontinuation
- 1998-10-12 CA CA002306086A patent/CA2306086A1/en not_active Abandoned
- 1998-10-12 NZ NZ503862A patent/NZ503862A/xx unknown
- 1998-10-12 AU AU95470/98A patent/AU9547098A/en not_active Abandoned
- 1998-10-12 JP JP2000515578A patent/JP2001519382A/ja active Pending
- 1998-10-12 TR TR2000/00958T patent/TR200000958T2/xx unknown
- 1998-10-12 SK SK531-2000A patent/SK5312000A3/sk unknown
- 1998-10-12 ID IDW20000669A patent/ID24521A/id unknown
- 1998-10-12 CN CN98812083A patent/CN1281359A/zh active Pending
- 1998-10-12 IL IL13551398A patent/IL135513A0/xx unknown
- 1998-10-12 OA OA1200000108A patent/OA11683A/en unknown
- 1998-10-12 WO PCT/GB1998/003064 patent/WO1999018943A1/en not_active Application Discontinuation
- 1998-10-12 EP EP98949086A patent/EP1023056A1/en not_active Withdrawn
- 1998-10-12 KR KR1020007003934A patent/KR20010024481A/ko not_active Application Discontinuation
- 1998-10-12 EA EA200000419A patent/EA002659B1/ru not_active IP Right Cessation
-
2000
- 2000-04-12 NO NO20001898A patent/NO20001898L/no not_active Application Discontinuation
- 2000-05-02 HR HR20000255A patent/HRP20000255A2/hr not_active Application Discontinuation
- 2000-05-05 BG BG104404A patent/BG104404A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9815219A (pt) | 2001-01-02 |
| JP2001519382A (ja) | 2001-10-23 |
| IL135513A0 (en) | 2001-05-20 |
| OA11683A (en) | 2005-01-12 |
| AU9547098A (en) | 1999-05-03 |
| CN1281359A (zh) | 2001-01-24 |
| HUP0003922A3 (en) | 2001-12-28 |
| AP2000001787A0 (en) | 2000-06-30 |
| GB9721693D0 (en) | 1997-12-10 |
| WO1999018943A1 (en) | 1999-04-22 |
| EA200000419A1 (ru) | 2000-10-30 |
| CA2306086A1 (en) | 1999-04-22 |
| BG104404A (bg) | 2000-12-29 |
| CZ20001297A3 (cs) | 2001-08-15 |
| KR20010024481A (ko) | 2001-03-26 |
| NZ503862A (en) | 2003-01-31 |
| EP1023056A1 (en) | 2000-08-02 |
| PL339813A1 (en) | 2001-01-02 |
| NO20001898L (no) | 2000-06-09 |
| TR200000958T2 (tr) | 2000-08-21 |
| ID24521A (id) | 2000-07-20 |
| EA002659B1 (ru) | 2002-08-29 |
| SK5312000A3 (en) | 2000-09-12 |
| NO20001898D0 (no) | 2000-04-12 |
| HUP0003922A2 (hu) | 2001-10-28 |
| HRP20000255A2 (en) | 2001-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY121517A (en) | Anticonvulsant derivatives useful in reducing blood glucose levels | |
| NZ262679A (en) | Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell | |
| MXPA03003870A (es) | Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes. | |
| EP1537861A3 (en) | Use of aminothiol compounds for the treatment xerostomia caused by therapeutic agents or radiation | |
| WO2003068170A3 (en) | Enzyme treatment of foodstuffs for celiac sprue | |
| AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
| EA200000814A1 (ru) | Фармацевтическая композиция топирамата | |
| MXPA05007470A (es) | Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2. | |
| AP9801174A0 (en) | Cyclic sulfone derivatives. | |
| WO2003096979A3 (en) | Drug therapy for celiac sprue | |
| HUP9800467A3 (en) | Use of hyaluronic acid for producing pharmaceutical compns. for the treatment of interstitial cystitis | |
| EP2075002A3 (en) | Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence | |
| EP0696456A3 (de) | Kombination von Nekrose-induzierenden Substanzen mit Substanzen, die durch Nekrosen aktiviert werden, zur selektiven Therapie von Tumoren und entzündlichen Erkrankungen | |
| CA2253130A1 (en) | A medicament for treating obesity and improving lipid metabolism | |
| DE59800935D1 (en) | Immuntolerante prothrombinkomplex-präparation | |
| HK1047707A1 (zh) | (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途 | |
| EP1007055A4 (en) | METHODS OF ADMINISTERING AMIFOSTINE | |
| BG104059A (en) | Diabetes treatment with rosiglytazone and insulin | |
| AU4133400A (en) | Cystic fibrosis medicaments | |
| PL323145A1 (en) | Transcutaneous therapeutic system (tts) for administering testosterone | |
| AU2787495A (en) | Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis | |
| NZ335125A (en) | Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof | |
| YU28800A (sh) | Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije | |
| AUPP823999A0 (en) | A treatment | |
| CA2234936A1 (en) | Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine |